These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23599406)

  • 1. Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.
    Rocchetti MT; Papale M; d'Apollo AM; Suriano IV; Di Palma AM; Vocino G; Montemurno E; Varraso L; Grandaliano G; Di Paolo S; Gesualdo L
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1115-25. PubMed ID: 23599406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
    Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.
    He Q; Shao L; Yu J; Ji S; Wang H; Mao Y; Chen J
    J Biomed Nanotechnol; 2012 Feb; 8(1):133-9. PubMed ID: 22515101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling.
    Graterol F; Navarro-Muñoz M; Ibernon M; López D; Troya MI; Pérez V; Bonet J; Romero R
    BMC Nephrol; 2013 Apr; 14():82. PubMed ID: 23577616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary podocyte can be an indicator for the pathogenetic condition of patients with IgA nephropathy.
    Shen P; Shen J; Li W; He L
    Clin Lab; 2014; 60(10):1709-15. PubMed ID: 25651718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic urinary proteome profile for immunoglobulin a nephropathy.
    Samavat S; Kalantari S; Nafar M; Rutishauser D; Rezaei-Tavirani M; Parvin M; Zubarev RA
    Iran J Kidney Dis; 2015 May; 9(3):239-48. PubMed ID: 25957429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study.
    Neprasova M; Maixnerova D; Novak J; Reily C; Julian BA; Boron J; Novotny P; Suchanek M; Tesar V; Kacer P
    Dis Markers; 2016; 2016():3650909. PubMed ID: 27799660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
    Suzuki H; Allegri L; Suzuki Y; Hall S; Moldoveanu Z; Wyatt RJ; Novak J; Julian BA
    Dis Markers; 2016; 2016():7806438. PubMed ID: 27647947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography.
    Kalantari S; Rutishauser D; Samavat S; Nafar M; Mahmudieh L; Rezaei-Tavirani M; Zubarev RA
    PLoS One; 2013; 8(12):e80830. PubMed ID: 24339887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy.
    Asao R; Asanuma K; Kodama F; Akiba-Takagi M; Nagai-Hosoe Y; Seki T; Takeda Y; Ohsawa I; Mano S; Matsuoka K; Kurosawa H; Ogasawara S; Hirayama Y; Sekine S; Horikoshi S; Hara M; Tomino Y
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1385-93. PubMed ID: 22700887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?
    Marek-Bukowiec K; Konieczny A; Ratajczyk K; Witkiewicz W
    Dis Markers; 2018; 2018():5205831. PubMed ID: 29606986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
    Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R; Tamaki K; Fujisawa M; Ikedo H; Haramaki N; Okuda S
    Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases.
    Julian BA; Wittke S; Haubitz M; Zürbig P; Schiffer E; McGuire BM; Wyatt RJ; Novak J
    World J Urol; 2007 Oct; 25(5):467-76. PubMed ID: 17619884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.
    Mucha K; Bakun M; Jaźwiec R; Dadlez M; Florczak M; Bajor M; Gala K; Pączek L
    Pol Arch Med Wewn; 2014; 124(7-8):380-6. PubMed ID: 24938435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
    Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers for the progression of IgA nephropathy.
    Maixnerova D; Reily C; Bian Q; Neprasova M; Novak J; Tesar V
    J Nephrol; 2016 Aug; 29(4):535-41. PubMed ID: 27142988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix-assisted laser desorption/ionization mass spectrometry imaging to uncover protein alterations associated with the progression of IgA nephropathy.
    Ivanova M; Dyadyk O; Ivanov D; Clerici F; Smith A; Magni F
    Virchows Arch; 2020 Jun; 476(6):903-914. PubMed ID: 31838587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.